Harbor BioSciences and CIPI Sign Umbrella Distribution Agreement
June 09, 2011 08:30 ET
|
Harbor BioSciences, Inc.
SAN DIEGO, June 9, 2011 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (OTCBB:HRBR) today announced that it has signed an umbrella generic drugs distribution agreement with China Institute of...
Harbor BioSciences Preclinical Study of Apoptone(R) in Breast Cancer Published in the International Journal of Breast Cancer
February 28, 2011 08:30 ET
|
Harbor BioSciences, Inc.
SAN DIEGO, Feb. 28, 2011 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (OTCBB:HRBR), a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory...
Initial Studies Show Harbor BioSciences' Triolex(R) for Parkinson's Disease Crosses the Blood-Brain Barrier in Mice
February 22, 2011 08:30 ET
|
Harbor BioSciences, Inc.
SAN DIEGO, Feb. 22, 2011 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (OTCBB:HRBR), which is investigating the use the company's proprietary compound Triolex® as a treatment for Parkinson's...
Harbor BioSciences Wraps Up Phase I/IIa Prostate Cancer Study
February 07, 2011 08:30 ET
|
Harbor BioSciences, Inc.
SAN DIEGO, Feb. 7, 2011 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (OTCBB:HRBR), a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory...
Harbor BioSciences Discovery of New Anti-Inflammatory Steroids Published in Peer Reviewed Scientific Journal
February 01, 2011 08:30 ET
|
Harbor BioSciences, Inc.
SAN DIEGO, Feb. 1, 2011 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (OTCBB:HRBR), a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory...
Harbor BioSciences Signs Pharmaceutical Development Agreements With China State Institute of Pharmaceutical Industry (CIPI)
January 18, 2011 08:30 ET
|
Harbor BioSciences, Inc.
SAN DIEGO, Jan. 18, 2011 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (OTCBB:HRBR), a leader in the development of a proprietary class of adrenal steroid hormones as novel pharmaceuticals, announced...
Harbor BioSciences Receives Patent for Triolex(R) and Other Compounds
September 20, 2010 08:00 ET
|
Harbor BioSciences, Inc.
SAN DIEGO, Sept. 20, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (Nasdaq:HRBR) today announced that the company has received patent No. 7,776,845 from the United States Patent and Trademark...
Harbor BioSciences Receives NASDAQ Notice of Delisting
September 17, 2010 17:00 ET
|
Harbor BioSciences, Inc.
SAN DIEGO, Sept. 17, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (Nasdaq:HRBR) received notification from NASDAQ that it has not complied with NASDAQ Listing Rule 5550(a)(2) and, unless the...
Harbor BioSciences Apoptone(R) for Prostate Cancer Shows a Partial Overall Response
September 14, 2010 16:30 ET
|
Harbor BioSciences, Inc.
SAN DIEGO, Sept. 14, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (Nasdaq:HRBR) a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory...
Harbor BioSciences Announces Closing of $2.06 Million Equity Financing
June 10, 2010 16:15 ET
|
Harbor BioSciences, Inc.
SAN DIEGO, June 10, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (Nasdaq:HRBR) announced today that it has closed its previously announced sale of approximately $2.06 million of its common stock...